Impact and Insight News blends space, science, technology, and combat sports into one forward-looking newsroom. We report where innovation, discovery, and human intensity intersect. This is where impact creates insight.
Follow us on social media:
Welcome to Science & Technology
Get link
Facebook
X
Pinterest
Email
Other Apps
-
This section covers research breakthroughs, emerging technologies, scientific discoveries, and cultural stories at the intersection of innovation and everyday life.
Nathan Arlow Tech & Future Science Writer Magnetically guided microrobots developed at ETH Zurich. Image credit: ETH Zurich. They swim through blood vessels, crawl along tissue, and carry medicines smaller than a speck of dust. 2025 has quietly become the year of the micro-robot. Once confined to speculative sketches and sci-fi storyboards, these machines now appear in peer-reviewed journals, press releases, and early clinical trials. At ETH Zurich, researchers demonstrated microrobots small enough to slip through capillary models and steer magnetically toward simulated clots. In July, a collaboration between the University of Michigan and Oxford University revealed micro-swimmers that can carry drug payloads through complex fluid environments while maintaining directional control. In September, the U.S. Food and Drug Administration granted Microbot Medical’s Liberty system a 510(k) clearance, marking the first time a company has won formal recogniti...
Elliot Fray Science Reporter Several CRISPR-based treatments for blood disorders and rare genetic diseases have entered broader multi-center evaluations this month, marking a cautious but meaningful expansion in gene-editing research. These trials build on earlier safety studies that demonstrated stable editing in targeted cells, though long-term impacts are still being closely monitored. Stylized CRISPR-Cas9 illustration showing DNA strands being cut. Image credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH (public domain). What the New Trials Are Designed to Measure The expanded studies focus on conditions such as sickle cell disease, beta-thalassemia, and select immune disorders where a single genetic change plays a major role in symptoms. According to publicly available trial protocols, researchers are emphasizing three areas: Editing efficiency: How consistently the CRISPR system edits the intended gene across large p...
Cass Valdez MMA Features Writer The story that no contender at 155 wanted finally hit the timeline. Ilia Topuria, the undefeated and newly crowned UFC lightweight champion, is stepping away from competition for at least the first quarter of 2026. He says he is going through a difficult moment in his personal life and wants to focus on his children and resolve the situation before he fights again. He is not vacating the title. He is pressing pause on the division and forcing everyone else to react. Ilia Topuria celebrates with UFC championship belts after stopping Charles Oliveira at UFC 317. Photo via Bloody Elbow / Getty Images. The Champion Hits Pause And The Division Has To Move On Ilia Topuria on Twitter Topuria made the announcement in a post on social media. He told fans he will not be fighting early next year, that he is dealing with a personal crisis, and that he does not want to hold up the division while he sorts his life ou...
Comments
Post a Comment